Malaria, diarrhea, respiratory infections, and cutaneous larva migrans are common travel-related infections observed in children and adolescents returning from trips to developing countries. Children visiting friends and relatives are at the highest risk because few visit travel clinics before travel, their stays are longer, and the sites they visit are more rural. Clinicians must be able to prepare their pediatric-age travelers before departure with preventive education, prophylactic and self-treating medications, and vaccinations. Familiarity with the clinical manifestations and treatment of travel-related infections will secure prompt and effective therapy.
Key points
- •
An increasing number of children are traveling to developing countries placing them at risk for malaria and traveler’s diarrhea.
- •
Children visiting friends and relatives are at a greater risk of acquiring a travel-related infection, such as malaria and typhoid fever.
- •
Travel-related infections are preventable through adherence to preventive measures such as insect bite protection, antimalarial prophylaxis, vaccination, and consumption of safe food and water.
- •
Clinicians must be familiar with the epidemiology and clinical manifestations of travel-related infections to assure prompt recognition and treatment.
Introduction
In 2011, international tourism arrivals increased by more than 4% to 982 million. An additional increase of 3%–4% was expected in 2012. Although much of the growth represents increased travel to Europe, travel to Southeast and South Asia, South America, and Africa has also increased. Fifty-one percent of travel was by air for leisure and recreation. Another 27% was for visiting friends and relatives (VFR), health, or religion. Some increases were to regions considered remote or exotic, which could pose different risks to travelers. Clinicians are expected to encounter pediatric travelers with malaria, travel-associated diarrhea, enteric fevers, and dermatoses such as cutaneous larva migrans. Although preventive measures are effective, certain at-risk populations, such as VFR travelers, are frequently unprepared and become ill.
In the assessment of the ill pediatric traveler, physicians must consider geographic, seasonal, and environmental factors and assess compliance to pretravel advice. A traveler taking an appropriate antimalarial agent as instructed is less likely to have malaria. Travelers to certain regions, such as Southeast Asia, are more likely to have dengue as the cause of their febrile illness. Travel to certain regions of southern Africa poses no risk for malaria or yellow fever.
VFR children pose a significant challenge. They tend to be younger and stay longer in high-risk and at times remote areas of developing countries. Children frequently become ill during or after travel. Children with malaria and typhoid fever are often hospitalized. A perception of low risk, a lack of access to a travel clinic or someone knowledgeable in travel medicine, refusal of medical insurance to cover pretravel care, and a lack of financial resources to purchase vaccines and prophylactic medications are among the reasons why most lack appropriate pretravel advice, antimalarial prophylaxis, or vaccinations. Many stay in family homes, which may increase their risk for acquiring certain diseases such as enteric infections. Many regions are endemic with dengue fever, yellow fever, typhoid fever, and malaria. A younger age places the child at greater risk of severe disease. In one study, 46% of VFR children were less than 5 years of age.
In a group of children whose family had visited a travel clinic for pretravel advice, diarrhea, abdominal pain, and fever were the most frequent posttravel complaints. Most episodes of illness occurred in the first 10 days of travel. In a large study of ill pediatric travelers, most had been tourists to Asia and sub-Saharan Africa or Latin America. Diarrhea (28%), dermatologic conditions, systemic febrile illnesses (23%), and respiratory conditions were most commonly reported. Travelers to sub-Saharan Africa were more likely to have malaria. Dermatologic conditions such as cutaneous larva migrans were more likely in children returning from Latin America.
This review addresses the most common infectious conditions observed among pediatric travelers. Discussion will be categorized according to presenting clinical features such as fever, diarrhea, and cutaneous conditions.
Introduction
In 2011, international tourism arrivals increased by more than 4% to 982 million. An additional increase of 3%–4% was expected in 2012. Although much of the growth represents increased travel to Europe, travel to Southeast and South Asia, South America, and Africa has also increased. Fifty-one percent of travel was by air for leisure and recreation. Another 27% was for visiting friends and relatives (VFR), health, or religion. Some increases were to regions considered remote or exotic, which could pose different risks to travelers. Clinicians are expected to encounter pediatric travelers with malaria, travel-associated diarrhea, enteric fevers, and dermatoses such as cutaneous larva migrans. Although preventive measures are effective, certain at-risk populations, such as VFR travelers, are frequently unprepared and become ill.
In the assessment of the ill pediatric traveler, physicians must consider geographic, seasonal, and environmental factors and assess compliance to pretravel advice. A traveler taking an appropriate antimalarial agent as instructed is less likely to have malaria. Travelers to certain regions, such as Southeast Asia, are more likely to have dengue as the cause of their febrile illness. Travel to certain regions of southern Africa poses no risk for malaria or yellow fever.
VFR children pose a significant challenge. They tend to be younger and stay longer in high-risk and at times remote areas of developing countries. Children frequently become ill during or after travel. Children with malaria and typhoid fever are often hospitalized. A perception of low risk, a lack of access to a travel clinic or someone knowledgeable in travel medicine, refusal of medical insurance to cover pretravel care, and a lack of financial resources to purchase vaccines and prophylactic medications are among the reasons why most lack appropriate pretravel advice, antimalarial prophylaxis, or vaccinations. Many stay in family homes, which may increase their risk for acquiring certain diseases such as enteric infections. Many regions are endemic with dengue fever, yellow fever, typhoid fever, and malaria. A younger age places the child at greater risk of severe disease. In one study, 46% of VFR children were less than 5 years of age.
In a group of children whose family had visited a travel clinic for pretravel advice, diarrhea, abdominal pain, and fever were the most frequent posttravel complaints. Most episodes of illness occurred in the first 10 days of travel. In a large study of ill pediatric travelers, most had been tourists to Asia and sub-Saharan Africa or Latin America. Diarrhea (28%), dermatologic conditions, systemic febrile illnesses (23%), and respiratory conditions were most commonly reported. Travelers to sub-Saharan Africa were more likely to have malaria. Dermatologic conditions such as cutaneous larva migrans were more likely in children returning from Latin America.
This review addresses the most common infectious conditions observed among pediatric travelers. Discussion will be categorized according to presenting clinical features such as fever, diarrhea, and cutaneous conditions.
Fever
Fever is a frequent manifestation of infection in children. Fortunately, most are mild and self-limiting and require no medical intervention. However, in a child returning from an endemic region, fever may be the initial presentation of a serious infection such as malaria, dengue, or enteric fever. Among hospitalized children returning from the tropics with febrile illnesses, diarrhea and malaria were the most common. A treatable cause was identified in only 46% of children. Eight percent of ill children returning from international travel were found to have malaria; 69% of these children required hospitalization. Most cases were caused by Plasmodium falciparum after travel to sub-Saharan Africa.
Because morbidity and mortality associated with travel to the tropics is significant, recognition and early treatment is imperative. Clinicians must differentiate between minor, self-limiting illnesses and diseases such as malaria, enteric fever, and infectious gastroenteritis. In most instances, fever will not be the only manifestation of disease. Chills, sweats, headaches, fatigue, neck pain, malaise, vomiting, diarrhea, and abdominal pain may be present and help with the clinical diagnosis. At times, clinical presentations in children will differ from those observed in adults. The well-described classical fever patterns associated with malaria in adults are rarely observed in children, in whom patterns are more erratic.
The etiologic diagnosis of a febrile illness is easier when the person traveled to an endemic area and returns to a nonendemic area. Specific incubation periods are helpful in determining a possible etiology. A too-short or too-long incubation period could eliminate some conditions. Box 1 lists diseases according to incubation period. Incubation periods of less than 14 days would support the diagnosis of malaria, dengue, and typhoid fever. Incubation periods greater than 14 days would rule out dengue. Known exposures to individuals with an infectious condition, such as measles or chickenpox, may help the clinician by providing a precise incubation period.
Incubation Period Less Than 14 Days
Malaria, dengue fever, rickettsial infections, leptospirosis, enteric fevers, diarrheal illnesses, viral respiratory infections, yellow fever, meningococcal and pneumococcal sepsis and meningitis
Incubation Period 2–6 Weeks
Malaria, enteric fevers, hepatitis A and E, acute schistosomiasis, leptospirosis, amoebic liver abscess, infectious mononucleosis, toxoplasmosis
Incubation Period Greater Than 6 Weeks
Malaria, tuberculosis, hepatitis B, visceral leishmaniasis, schistosomiasis, amoebic liver abscess, brucellosis, visceral larva migrans
Plasmodium falciparum is the most common species of malaria acquired in West Africa. It has the highest morbidity and mortality. If suspected, prompt effective treatment is required.
In travelers to Southeast Asia and South and Central America, leptospirosis and dengue fever have become more common causes of undifferentiated fevers than malaria. Dengue fever was responsible for 6% of systemic febrile illnesses among ill-returning children. In the Amazon basin of Ecuador, leptospirosis was the most common cause of acute undifferentiated fever (13.2%), followed by malaria (mostly Plasmodium vivax ) at 12.5%. Rickettsial infections were also seen. Many of these conditions are indistinguishable, requiring molecular or serologic diagnostic testing.
Enteric fevers caused by Salmonella typhi or Salmonella paratyphi are rarely acquired in developed countries. Although foodborne outbreaks of typhoid fever have been reported in the United States in recent years, most cases are acquired from travel to developing countries, especially India and Pakistan. Overall, typhoid fever was responsible for only 1% of febrile illnesses among returning pediatric travelers seeking medical care. VFR children represent a large number of reported infections.
In diarrheal infections caused by nontyphoidal Salmonella spp. and Shigella spp., fever can be an associated feature. Most travel-related diarrheal infections occur in children less than 2 years, most while the person is still traveling. Prolonged disease was common, and many required hospitalization. Among ill-returned pediatric travelers, diarrheal infections represented 28% of all pediatric illnesses.
More than 30% of febrile illnesses are caused by more cosmopolitan-type infections, such as acute otitis media, pharyngitis, infectious mononucleosis, and soft tissue and urinary tract infections.
Clinical syndromes or examination findings may lead to a diagnosis. A child with a sepsis-like presentation may have a life-threatening infection like typhoid fever, meningitis, leptospirosis, or malaria. Coughing and tachypnea may represent a pneumonic process. Fever and jaundice may represent leptospirosis or hepatitis A or E. Meningismus, headache, vomiting, and photophobia, all suggest a central nervous system infection. Purpura may suggest meningococcal disease, whereas eschars and chagomas may support the diagnosis of rickettsioses or Chagas disease, respectively. The presence of lymphadenopathy, tonsillitis, and hepatosplenomegaly would suggest infectious mononucleosis. A person with fever and polyarthropathy arriving from northern Australia may have Ross River fever, but a traveler returning from an island in the Indian Ocean with the same symptoms may have Chikungunya. Box 2 provides differential diagnoses according to syndromic features.
Fever and Hepatitis
Hepatitis A, B, and E; leptospirosis, infectious mononucleosis, amebiasis (eg, liver abscess)
Fever and Eosinophilia
Schistosomiasis (eg, Katayama fever), ascariasis, strongyloidiasis
Fever and Lymphadenopathies
Toxoplasmosis, Epstein-Barr virus (mononucleosis-like), cytomegalovirus, tularemia, human immunodeficiency virus (eg, acute retroviral syndrome), brucellosis
Fever and Arthropathies
Ross River virus, Chikungunya virus, dengue fever, pyogenic septic arthritis, acute rheumatic fever, human parvovirus B19
Fever and Diarrhea
Shigellosis, salmonellosis, amebiasis, Campylobacteriosis, Clostridium difficile enteritis, diarrheagenic Escherichia coli , rotavirus
Fever—Chronic, Relapsing, Recurrent
Malaria, relapsing fever, enteric fever, brucellosis, Q fever, leptospirosis, Familial Mediterranean fever
Fever and Hemorrhagic Manifestations
Dengue fever, yellow fever, Lassa fever, Rift Valley fever, viral hemorrhagic fevers (eg, Machupo, Marburg, Ebola), meningococcal
Fever and Exanthem (Type)
Dengue fever (maculopapular), Chikungunya (maculopapular), measles (maculopapular), rubella (maculopapular), rickettsial (maculopapular, eschar, petechial, vesiculopustular), Neisseria meningitidis (petechial, purpura), enterovirus (maculopapular), drug reactions (erythema multiforme), varicella-zoster virus (vesicular), tuberculosis (erythema nodosum, papulonecrotic tuberculids), yellow fever (maculopapular)
Fever and Central Nervous System Disease
N meningitidis meningitis, Streptococcus pneumoniae meningitis, enterovirus, malaria, arboviral meningoencephalitis, rabies, Japanese encephalitis virus, West Nile virus, tuberculosis, Angiostrongylus (eg, eosinophilic meningitis)
Fever and Abdominal Pain
Enteric fevers (eg, typhoid, paratyphoid), yersiniosis, adenovirus, liver abscess
Fever, Respiratory Symptoms, and Pneumonia
Pneumococcal, influenza, respiratory syncytial virus, tuberculosis, histoplasmosis, coccidioidomycosis, adenovirus, legionellosis, Q fever, plague, tularemia, diphtheria, anthrax, hantavirus
An initial workup for fever in a returning pediatric traveler may consist of a complete blood count and differential, liver function tests, blood cultures, stool culture, urinalysis, and thick and thin smears for malaria. Serologic testing is needed to confirm dengue. Patients with a cough may require a chest film, and evidence of pneumonic infiltrates may require respiratory viral testing or sputum for gram stain and culture. Tuberculin skin testing or interferon-γ release assays may be required to confirm the diagnosis of tuberculosis in a young child with an atypical or complex disease. A stool culture may be useful in patients with diarrhea, as determined by the duration and type of symptoms; some may require testing for Clostridium difficile toxin. Examination for ova and parasites may be useful in persons with chronic diarrhea. Antigen assays for Cryptosporidium and Giardia are particularly sensitive. Individuals with complaints of pharyngitis and evidence of exudative disease would benefit from rapid streptococcal antigen assay with a backup throat culture (or polymerase chain reaction [PCR]) if necessary. Patients with symptoms suggestive of meningitis require a lumbar puncture. Some individuals may require diagnostic imaging with a computed tomography scan or magnetic resonance imaging. Joint aspiration is required for patients with suspected pyogenic septic arthritis.
Malaria
Epidemiology
Malaria is a mosquito-borne protozoa infection caused by erythrocyte-infecting Plasmodium species. The most important species infecting humans are P falciparum, P vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi . The major vector is the Anopheles mosquito, which is endemic in many regions of the world, including the United States. Regions of the world with the most malarial transmission are sub-Saharan Africa, Southeast Asia-Pacific, Amazonian South America, and parts of Central America. P knowlesi is widely distributed in Malaysian Borneo, Peninsular Malaysia, and the Philippines.
Resistance to antimalarial agents in P falciparum contributed to its uncontrolled prevalence in Africa. Outside Central America, most P falciparum strains are resistant to chloroquine. P falciparum is resistant to mefloquine in some Asian countries (ie, regions bordering Thailand, Myanmar, Laos, and Cambodia). P vivax is the most prominent species outside Africa, especially in Asia where better diagnosis and antimalarial treatments are available, resulting in less P falciparum . However, resistance does not escape P vivax . Chloroquine resistance is reported in areas of Indonesia and Malaysia. Plasmodium ovale is rarely observed outside Africa. Recently, resistance to artemisinin compounds has been reported in Southeast Asia.
Clinical Manifestations
Nonspecific clinical features are usually observed in children. Fever, vomiting, headaches, chills, myalgias, and anorexia are common. Gastrointestinal symptoms, such as diarrhea, abdominal pain, and distension are also observed. Thrombocytopenia is frequently seen.
Severe malaria may result from cerebral involvement, acute respiratory distress syndrome, severe malarial anemia, or multiorgan involvement. Most children with severe malaria will die unless they are hospitalized and promptly treated with effective support and antimalarial medications. Coma, seizures, metabolic acidosis, profound hypoglycemia, and shock are associated with high mortality. Although most of the serious complications are observed with P falciparum, severe malarial anemia in young infants is seen frequently with P vivax.
Diagnosis
Visualization of the parasite on blood smears has been the method of choice for malaria diagnosis for decades. Unfortunately, there is great variability of practitioners’ ability to perform proper microscopy. The use of rapid diagnostic tests (RDTs) is becoming more widespread. In a laboratory-based study, RDT performed better than the Giemsa-stained blood smears (GS). Rapid antigen capture assay (BinaxNOW Malaria test; Alere, Waltham, MA) had a sensitivity of 97% compared with 85% of GS with a negative predictive value of 99.6% versus 98.2% with GS for all malaria. The sensitivity was 100% for P falciparum. Most RDTs are less effective in the diagnosis of P malariae , P ovale or P knowlesi than P falciparum or P vivax . In addition, they cannot quantify parasitemia level, which is important when following a patient’s response to therapy. For this reason, in centers in which high-quality microscopy is available, it remains the test of choice for diagnosis of malaria. RDTs can be used adjunctively or in centers in which high-quality microscopy is not available. PCR has the highest sensitivity for detection of infection and can be used to detect all 5 species that infect humans. However, its availability is still limited, and it typically cannot be run immediately in the way that microscopy can. In a study from Thailand, loop-mediated isothermal amplification was compared with nested PCR and microscopy. Loop-mediated isothermal amplification is a molecular method that compares favorably with PCR but is cheaper, simpler, and faster. Using PCR as a gold standard, loop-mediated isothermal amplification detected 100% of blood specimens with P falciparum with 100% specificity. Microscopy showed 92% sensitivity and 93% specificity. Loop-mediated isothermal amplification performed just as well with specimens containing P vivax, whereas microscopy detected only 68% of positive specimens. The new fluorescent assay, Partec Rapid Malaria Test, may be easier to perform and provides quicker results compared with GS.
Management
Recently, the World Health Organization updated its guidelines for malaria treatment. Treatment recommendations for uncomplicated and severe malaria are briefly summarized below, but the reader is referred to the Centers for Disease Control (CDC) Web site for full guidelines for the treatment of severe and uncomplicated malaria ( http://www.cdc.gov/malaria/diagnosis_treatment/clinicians2.html ).
Artemisinin-based combinations are the recommended treatment for uncomplicated chloroquine-resistant P falciparum malaria. Artemether-lumefantrine, artesunate plus amodiaquine, artesunate plus mefloquine, and artesunate plus sulfadoxine-pyrimethamine are being used throughout the world. Of these, only artemether-lumefantrine (Coartem, Novartis Pharmaceuticals Corporation, Basel, Switzerland) is licensed in the United States. Artemether-lumefantrine therapy is given for 3 days. Other effective treatments available in the United States for uncomplicated malaria include atovaquone-proguanil, or quinine plus tetracycline or doxycycline or clindamycin. Uncomplicated malaria caused by chloroquine susceptible P falciparum (generally limited to Haiti and Central America west of the Panama Canal) can be treated with chloroquine.
Severe malaria is always a medical emergency. Parenteral antimalarial treatment should be started immediately. Therapy should be started with whichever effective antimalarial is first available. Parenteral antimalarials are usually administered intravenously for a minimum of 24 hours and then switched to an oral regimen. In the United States, parenteral quinine is not available, so intravenous quinidine is the current drug of choice for severe malaria. Artesunate is superior to quinine in the treatment of severe malaria but is not yet US Food and Drug Administration approved for treatment of severe malaria in the United States and is not widely available. It is available from the CDC for patients who cannot tolerate quinidine or have a contraindication to quinine. The CDC malaria hotline can be reached at 770-488-7788 or 855-856-4713 (toll free), Monday through Friday, 9 am –5 pm , and emergency consultation after hours can be obtained by calling 770-488-7100 and requesting to speak to the Malaria Branch clinician. Although a 3-case series of adults with severe P falciparum malaria who were treated successfully with oral artemether-lumefantrine alone has been reported, these patients had laboratory and not clinical criteria for severe malaria. Oral therapy is not appropriate in any case of severe pediatric malaria, but if quinidine is not immediately available and oral therapy is available, it should be given while awaiting the quinidine therapy.
Chloroquine combined with primaquine is the treatment of choice for chloroquine-susceptible P vivax infections. An artemisinin-based combination regimen is recommended for infections suspected to be caused by chloroquine-resistant P vivax. Primaquine is recommended for 14 days to eliminate the hepatic hypnozoite stage and prevent relapses. Severe P vivax or P knowlesi infections should be treated with artemisinin combination regimens. To avoid medication-induced hemolysis, testing to rule out glucose-6-phosphate dehydrogenase deficiency is advised before treating with primaquine. There is currently a shortage of primaquine in the United States. Full details on appropriate medication for treatment of all Plasmodium species that infect humans are available on the CDC Web site noted above.
Children with severe malaria presenting with respiratory distress and metabolic acidosis benefit from blood transfusions. Close monitoring for hypoglycemia is imperative. Seizures can be a complication of cerebral malaria or profound hypoglycemia.
Enteric fever
Epidemiology
Enteric fever, an infection caused by Salmonella enterica serotype Typhi (typhoid fever) or S enterica serotype Paratyphi A, B, C (paratyphoid fever), is a frequent cause of morbidity and mortality in many parts of the world. Most infections occur in Southern and Southeast Asia. Parts of Africa and Latin America are affected but at a lower frequency. It is estimated that 22 million cases occur worldwide each year, with more than 200,000 deaths. Infections from S paratyphi A are becoming more frequent than those from S typhi among travelers.
The major factor responsible for the magnitude of this problem is poor sanitary infrastructure resulting in substandard drinking water and contaminated food. Person-to-person transmission from chronic asymptomatic infections among inhabitants also contributes to the infection of susceptible individuals.
Clinical Manifestations
Although fever, gastrointestinal symptoms (eg, vomiting, severe diarrhea, abdominal distension, pain), cough, relative bradycardia, rose spots, and splenomegaly are frequently regarded as features of typhoid and paratyphoid fever, many patients lack these, making diagnosis difficult if solely based on clinical features. Jaundice is frequently observed among children. In a study of travelers with enteric fever, clinical and laboratory features were indistinguishable between S typhi and S paratyphi, which suggests that milder disease is not always observed with S paratyphi as originally thought. Unfortunately, early features of enteric fever mimic other conditions such as pneumonia, malaria, sepsis, dengue, acute hepatitis, and rickettsial infections.
Children younger than 5 years had more severe disease. More than 95% of these children had fever, 20%–41% hepatomegaly, 5%–20% splenomegaly, 19%–28% abdominal pain, and 8%–35% diarrhea. Intestinal perforation was a rare complication. Cough was observed in approximately 15% of patients. Thrombocytopenia and disseminated intravascular coagulation are markers of severe disease.
Relative bradycardia and rose spots are seldom observed in children. Febrile convulsions have been reported in children with enteric fever and may be the presenting symptom. Because typhoid fever vaccines are only approximately 50% effective, the diagnosis needs to be considered even in vaccinated children.
Diagnosis
Blood cultures are frequently positive, stool, less so, but both should be obtained, as this increases the likelihood of detection of infection. Repeated blood cultures yield a sensitivity of approximately 80% for detection of enteric fever. Although liver enzymes are frequently elevated, leukocytosis is not always observed. However, leukocytosis is more frequently observed in children than adults. Leukopenia and anemia are frequently associated with enteric fevers. Many suggest that bone marrow cultures have a higher sensitivity. However, obtaining this type of specimen is invasive and impractical under most circumstances.
The Widal test, a classical test that measures antibodies against O and H antigens of S typhi, was used in the past to diagnose typhoid fever and is still used frequently in low- and middle-income countries for this purpose, but it lacks sensitivity and specificity and should not be used as a diagnostic test for typhoid fever. Newer pathogen-specific serologic are an improvement on the Widal test but still lack acceptable sensitivity and specificity. Multiplex PCR assays show promise, but are not yet widely tested to fully assess sensitivity and specificity and are not commercially available.
Management
Amoxicillin and trimethoprim-sulfamethoxazole are no longer recommended as first-line agents because of a high frequency of treatment failures, resistance, and relapse. Relapse rates in children are 2%–4% after therapy, whereas carrier rates occur in fewer than 2% of infected children. Antimicrobial resistance observed in many countries has influenced the choice of agent for treating typhoid and paratyphoid fevers. Ceftriaxone is the recommended agent in severe cases when parenteral therapy is indicated. Azithromycin is an oral alternative for nonsevere cases. Although fluoroquinolones are generally associated with high cure rates, defervescence within a week, and lowered relapse and fecal carriage rates, isolates from many Asian countries show resistance, rendering them ineffective.
Proper hydration, perfusion, and fever control are integral components of treating enteric fever. Mixed infections with multiple pathogens can occur. Treatment against enteric fever should be considered for children with unremitting fevers after completing adequate antimalarial therapy.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree